TGF-|ARI inhibitor 1
(E)-3-[6-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-5-yl]prop-2-enamide
Molecular Identity
TGF-|ARI inhibitor 1
(E)-3-[6-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-5-yl]prop-2-enamide
PubChem CID: 132246793
2D Structure
Properties
C21H19N7O
Molecular Formula
385.40
Molecular Weight
g/mol
385.1651
Exact Mass
Da
1.4
XLogP
Drug-like (Lipinski: < 5)
104
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
5
H-Bond Acceptors
643
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(15)
TGF-|ARI inhibitor 1GFH018CHEMBL55180042169299-67-4orb2565179SCHEMBL19732243SCHEMBL30367008GFH-018EX-A7902BDBM50637946NSC858008NSC-858008HY-160215CS-0926809(2E)-3-[6-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl][1,2,4]t riazolo[1,5-a]pyridin-5-yl]-2-Propenamide,
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to TGF-|ARI inhibitor 1
Loading drug network...